Loading company details...
Beta
Latest Form 4 (Aug 6, 2024): John C. McKew (Chief Scientific Officer): Sale of 3,407 shares, $6.4K.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2024 | John C. McKew, Chief Scientific Officer | Sale | 3,407 | $6.4K |
| Aug 5, 2024 | Lori D. Lawley, Chief Financial Officer | Tax Withholding | 229 | $409.91 |
| Aug 5, 2024 | John C. McKew, Chief Scientific Officer | Tax Withholding | 1,593 | $2.9K |
| Jul 3, 2024 | Pisit Duke Pitukcheewanont, Chief Medical Officer | Tax Withholding | 274 | $620.06 |
| Jun 7, 2024 | Es-Johansson An Van | Grant/Award | 3,328 | n/a |
| Jun 7, 2024 | Joseph S. McCracken | Grant/Award | 3,328 | n/a |
| Jun 7, 2024 | Chad Allen Johnson | Grant/Award | 3,328 | n/a |
| Jun 7, 2024 | Lota S. Zoth | Grant/Award | 3,328 | n/a |
| Jun 7, 2024 | Thomas A. Raffin | Grant/Award | 3,328 | n/a |
| Jun 7, 2024 | Kevin M. Lalande | Grant/Award | 3,328 | n/a |